IPCA Laboratories

Price chart

Previous close

₹1,938.70

Open

₹1,950.00

Day high

₹1,991.70

Day low

₹1,928.30

Listed on NSE since 8 February 1995.

Market value

₹49,264 Cr

P/E (trailing)

35.13

EPS (trailing)

₹55.28

Price to book

5.68

Dividend yield

0.31%

Return on equity

15.6%

Debt to equity

0.07

Profit margin

13.4%

Volume today

1.85 L

Average volume

4.10 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: IPCA Laboratories’s results filed with NSE, consolidated (the whole group). Net profit is the share of IPCA Laboratories’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: IPCA Laboratories’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetes, diabetology, emollients/protectives, fever, gastroenterology, haematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, regenerative, respiratory, rheumatology, and urology. The company also exports its products to Europe, Africa, the Americas, rest of Asia, the Commonwealth of Independent States, and Australasia. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

17,210

Company website · Profile: Yahoo Finance

No headlines name IPCA Laboratories in the last day or two.

• Dividend - Rs 6 Per Share

  Dividend · ex-date 7 August 2026

• Dividend - Rs 2 Per Share

  Dividend · ex-date 5 August 2025

• Interim Dividend - Rs 2 Per Share

  Dividend · ex-date 27 November 2024

• Annual General Meeting/Dividend - Rs 2 Per Share

  Dividend · ex-date 6 August 2024

• Interim Dividend - Rs 2 Per Share

  Dividend · ex-date 22 November 2023

• Interim Dividend - Rs 4 Per Share

  Dividend · ex-date 22 November 2022 · record date 23 November 2022

• Annual General Meeting

  Action · ex-date 3 August 2022

• Face Value Split (Sub-Division) - From Rs 2/- Per Share To Re 1/- Per Share

  Split · ex-date 10 January 2022 · record date 11 January 2022

Source: NSE. Latest first, 8 of 20.